• About
  • Subscribe
  • Advertise
  • Contact
Tuesday, July 14, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home

Speqs raises $10 million, considers ASX listing

by Staff Writer
June 9, 2017
in Equipment
Reading Time: 4 mins read
A A
Share on FacebookShare on Twitter

Mr Neven Botica, a Perth-based businessman with a background in manufacturing and distribution, also said the company board would attpt to generate further investment and did not rule out a potential ASX debut in the near future.To date, capital raising efforts have easily exceeded the $3 million target initially stated in the business’s March information morandum, as first reported by Insight in July.A soft launch of the company’s augmented reality platform, that should allow potential customers to ‘virtually try on’ frames, was scheduled for late August. However, while the website is now ‘live’, Botica said the smartphone app was undergoing some additional testing and would now be released by mid-Septber.{{quote-A:R-W:400-I:2-Q: It’s technology which is going to change the way people purchase their eyewear… To my knowledge there is nothing else in the world that can do this right now, -WHO:Neven Botica, Speqs CEO}}Botica claims the software is sufficiently advanced to take PD measurents and perform other work normally undertaken by dispensers, and will also allow multi-focal wearers to purchase spectacles online.Such a development would be significant, and controversial, given online retailers have traditionally been reluctant to sell spectacles with anything other than low-power single vision lenses due to the complicated nature of aspheric lenses.Botica described Speqs as a world first a-commerce (augmented reality commerce) platform saying, “It’s an augmented reality virtual try on technology, so we’re going to have one of the first a-commerce platforms in the world.“It’s technology which is going to change the way people purchase their eyewear… To my knowledge there is nothing else in the world that can do this right now.”Botica also revealed plans for international expansion and said the company would exhibit at this month’s Vision Expo in Las Vegas.“We’ve got a distribution platform with our technology, which is a different way of doing business. We’re dealing with various suppliers and we have other relationships that we’re trying to develop,” Botica said.“Australia has a very mature eyewear market. If we can prove this model works in Australia, well there’s no reason why it’s not going to work everywhere around the world.”The ambitious company has targeted $25 million in online sales in 2018, which would in part be assisted by cross marketing campaigns with major health funds. A spokesperson for Whitecoat, which reached an agreent with Speqs in March, said the two businesses had been working on a number of marketing strategies to help generate website traffic for the start up.“We will list Speqs on Whitecoat, and allow customers to download the Speqs app from the Whitecoat website. The site currently has more than 250,000 monthly visitors, researching providers and reading reviews. Secondly, we will send Whitecoat surveys to Speqs customers, allowing th to give their feedback on the service experience,” the Whitecoat spokesperson said.“We also will introduce Speqs to funds who are using the Whitecoat platform, so they can pursue cooperative marketing with those funds. Finally, for consumers who have opted in to marketing updates from Whitecoat, we will promote Speqs to th to raise awareness of the proposition and provide great offers as well.”{{quote-A:L-W:400-I:3-Q: Australian consumers increasingly manage many aspects of their everyday lives through their mobile. We believe that healthcare matters should be managed in the same way, -WHO:Whitecoat spokesperson}}The spokesperson said the move toward online platforms was a “natural progression” given that 80% of people access whitecoat.com.au via a mobile device.“Australian consumers increasingly manage many aspects of their everyday lives through their mobile. We believe that healthcare matters should be managed in the same way. The Speqs proposition is fully aligned to this view,” the spokesperson said.HBF has also indicated it will market Speqs to mbers should it become an HBF Mber Plus provider, however, there is no formal agreent between the two businesses as yet.A HBF spokesperson explained: “We have Mber Plus agreents with many providers and marketing on behalf of our different providers, optical and other, is something we routinely do where we see a tangible benefit for mbers.

“Currently there is no agreent between HBF and Speqs, but we are in discussions with th and rain interested in anything that has the potential to deliver value to our mbers,” he added.Aside from spectacles, Speqs also has plans to branch into the online contact lens market and has developed an app to launch alongside its spectacles platform. It’s understood the current version of the app will allow consumers with an up-to-date prescription to purchase contact lenses online, but will stop short of virtual eye exams like those offered by Warby Parker and Opternative in the US.More reading: Australian online optical retailer aims to disrupt market

Related Posts

Optometrist Dr Toral Patel who celebrated the Optos milestone, said her clinic was focused on delivering the highest standard of care through innovation and collaboration. Image: Optos.

Optos celebrates global milestone of 30,000 devices installed

by Helen Carter
July 6, 2026

Optos PLC, a pioneer in retinal imaging technology, has achieved a global milestone of installing 30,000 devices worldwide. CEO Alexandre Montague...

Dr Yachana Shah (right) and husband Dr Vaibhav Shah
in Broome. Image: Yachana Shah.

They go together like . . . Bausch + Lomb

by Rob Mitchell
June 29, 2026

Partnerships can be powerful things. One Western Australian ophthalmologist who has set up a clinic with her husband has found...

Optos will demonstrate how optomap technology can enhance clinical decision-making, improve patient flow, and increase practice efficiency. Image: Optos.

Optos to showcase ultra-widefield imaging technology at key events in 2026

by Staff Writer
April 23, 2026

Optos is continuing to support eyecare professionals across Australia and New Zealand in 2026, bringing its industry-leading innovation to key...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Products
    • Ophthalmic Treatments
      • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited